Company Filing History:
Years Active: 2017
Title: Innovations of Ryan Mitchell Minikis: A Pioneer in Btk Inhibition
Introduction
Ryan Mitchell Minikis, based in Bend, OR, is an inventor making significant strides in the field of pharmaceuticals. With a focus on Bruton's tyrosine kinase (Btk) inhibitors, his contribution addresses critical healthcare challenges, making a notable impact in the treatment of autoimmune diseases and cancers.
Latest Patents
Ryan holds a patent for his formulation of a Bruton's tyrosine kinase inhibitor, specifically designed as 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. This innovative formulation includes novel pharmaceutical compositions that not only encompass the Btk inhibitor but also highlight methods of using the compound, alone or in conjunction with other therapeutic agents. This invention aims to provide treatment options for autoimmune and heteroimmune diseases, lymphoma, and various inflammatory conditions.
Career Highlights
Ryan is associated with Pharmacyclics, Inc., where he cultivates his expertise in pharmaceutical development and innovation. His patent reflects an intensive commitment to advancing therapeutic options in oncology and autoimmune disorders. Ryan’s work at Pharmacyclics underscores the importance of incorporating research and development into viable medical solutions.
Collaborations
Throughout his career, Ryan has collaborated with talented professionals such as Cassandra Shu and Harisha Atluri. These partnerships contribute to a dynamic research and development environment, fostering innovation and bringing new ideas to fruition in the pharmaceutical landscape.
Conclusion
Ryan Mitchell Minikis exemplifies the spirit of innovation in pharmaceutical science. With his patented formulation of Bruton's tyrosine kinase inhibitors, he is positioning himself as an influential figure in combating serious health issues. His contributions not only demonstrate the power of inventive thinking but also highlight the importance of collaboration in driving advancements within the medical field.